Fidelity Investments’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Fidelity Investments’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-342	Closed	-$3.82K	–	5671
2022 Q4	$3.82K	Buy	342 +49	+17%	+$475	﹤0.01%	4336
2022 Q3	$2K	Hold	293	–	–	﹤0.01%	4615
2022 Q2	$1K	Buy	293 +212	+262%	+$1.21K	﹤0.01%	4855
2022 Q1	$1K	Buy	+81	New	+$964	﹤0.01%	4892

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity Investments's OYST Position: Q1 2023 in Review

Fidelity Investments sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 342 shares — an estimated $3.82K sold.

Fidelity Investments first reported a position in OYST in Q1 2022 and held it in 4 quarters. The position peaked at $3.82K in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Fidelity Investments reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Fidelity Investments sold 342 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $3.82K.
Fidelity Investments first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Fidelity Investments's Oyster Point Pharma, Inc. Common Stock position peaked at $3.82K in Q4 2022.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.